GeneMatters Funding: How Much Did They Raise & Key Investors

How Much Did GeneMatters Raise?
Funding & Key Investors

GeneMatters has secured $350K in total capital, with its most recent financing round bringing in $350K. This significant strategic investment underscores the company's established position in the market and its trajectory towards further expansion. The company's financial activities indicate a mature stage of growth, likely leveraging this capital for scaling operations and enhancing its service offerings.

What is GeneMatters?

GeneMatters

Hospitals & Physicians Clinics

Medical Practice Management

Healthcare Services

GeneMatters operates within the burgeoning telehealth sector, specializing in genetic counseling services. The company offers an online platform designed to streamline and improve patient access to essential genetic counseling, addressing a critical need for timely and efficient healthcare solutions. Based in Minneapolis, Minnesota, GeneMatters is positioned to capitalize on the increasing demand for personalized medicine and genetic diagnostics.

How much funding has GeneMatters raised?

GeneMatters has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

What's next for GeneMatters?

With a substantial funding history, GeneMatters is poised for significant advancements. The large-scale, late-stage capital infusion suggests a focus on market penetration, potential technological enhancements to its platform, and possibly strategic partnerships. The company's strategic investment indicates confidence from backers in its business model and its capacity to scale effectively within the competitive healthcare technology landscape. Future developments are likely to center on expanding service reach and deepening its impact on patient care.

See full GeneMatters company page

See More Financial Insights